Fate Therapeutics Inc. (FATE)
NASDAQ: FATE
· Real-Time Price · USD
1.00
0.03 (3.01%)
At close: Sep 26, 2025, 3:59 PM
1.01
0.97%
After-hours: Sep 26, 2025, 07:17 PM EDT
3.01% (1D)
| Bid | 0.99 |
| Market Cap | 115.33M |
| Revenue (ttm) | 8.47M |
| Net Income (ttm) | -171.52M |
| EPS (ttm) | -1.46 |
| PE Ratio (ttm) | -0.68 |
| Forward PE | -0.92 |
| Analyst | Hold |
| Dividends | n/a |
| Ask | 1 |
| Volume | 1,300,531 |
| Avg. Volume (20D) | 1,482,788 |
| Open | 0.98 |
| Previous Close | 0.97 |
| Day's Range | 0.95 - 1.01 |
| 52-Week Range | 0.66 - 3.80 |
| Beta | 2.22 |
| Ex-Dividend Date | n/a |
About FATE
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol FATE
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for FATE stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsFate Therapeutics Inc. is scheduled to release its earnings on
Nov 11, 2025,
after market closes.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
1 month ago
+20.69%
Fate Therapeutics shares are trading higher after ...
Unlock content with
Pro Subscription
5 months ago
+21.17%
Fate Therapeutics shares are trading higher after the FDA recently granted Regenerative Medicine Advanced Therapy designation to FT819.
